Penidihydrocitrinins A-C: New Polyketides from the Deep-Sea-Derived Penicillium citrinum W17 and Their Anti-Inflammatory and Anti-Osteoporotic Bioactivities

Mar Drugs. 2023 Oct 14;21(10):538. doi: 10.3390/md21100538.

Abstract

Three new polyketides (penidihydrocitrinins A-C, 1-3) and fourteen known compounds (4-17) were isolated from the deep-sea-derived Penicillium citrinum W17. Their structures were elucidated by comprehensive analyses of 1D and 2D NMR, HRESIMS, and ECD calculations. Compounds 1-17 were evaluated for their anti-inflammatory and anti-osteoporotic bioactivities. All isolates exhibited significant inhibitory effects on LPS-stimulated nitric oxide production in murine brain microglial BV-2 cells in a dose-response manner. Notably, compound 14 displayed the strongest effect with the IC50 value of 4.7 µM. Additionally, compounds 6, 7, and 8 significantly enhanced osteoblast mineralization, which was comparable to that of the positive control, purmorphamine. Furthermore, these three compounds also suppressed osteoclastogenesis in a dose-dependent manner under the concentrations of 2.5 μM, 5.0 μM, and 10 μM.

Keywords: Penicillium citrinum; anti-inflammation; anti-osteoporosis; deep-sea; fungus; polyketides.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Mice
  • Molecular Structure
  • Penicillium* / chemistry
  • Polyketides* / chemistry
  • Polyketides* / pharmacology

Substances

  • Polyketides
  • Anti-Inflammatory Agents

Supplementary concepts

  • Penicillium citrinum